Formulation and Optimization of Ansamycin-Loaded Polymeric Nanoparticles Using Response Surface Methodology for Bacterial Meningitis

被引:12
作者
Nair, Keerthi G. S. [1 ]
Velmurugan, Ramaiyan [1 ]
Sukumaran, Sathesh Kumar [1 ]
机构
[1] Vels Inst Sci Technol & Adv Studies, Sch Pharmaceut Sci, Chennai 600117, Tamil Nadu, India
关键词
Ansamycin; Polymeric nanoparticles; Response surface methodology; Central composite rotatable design; NANOCOMPOSITES; RELEASE; DELIVERY;
D O I
10.1007/s12668-019-00713-0
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Response surface methodology utilizing the central composite rotatable design version was made use of to optimize formulation of ansamycin-loaded polymeric nanoparticles. The central composite rotatable design including three-factored factorial designs with 3 levels was utilized in this research study. The drug encapsulation efficiency, particle size and zeta potential of the nanoparticles were examined relative to 3 independent variables consisting of polymer concentration (X1), surfactant concentration (X2) and also proportion of organic to aqueous phase volume (X3). The outcome revealed that the ideal formula can be gotten from this response surface methodology. The ideal solution for the nanoparticles was made up of polymer concentration (X1) of 5% w/v, surfactant concentration (X2) of 1% w/v and also proportion of aqueous to organic phase volume (X3) of 10:1 v/v. Ansamycin nanoparticles under the optimized conditions generated the encapsulation efficiency of 89%, mean particle size of 121 nm and zeta potential value of - 25 mV. SEM of the optimized polymeric nanoparticle showed spherical particles. The in vitro experiments verified that ansamycin in the polymeric nanoparticles released progressively over the duration of 36 h. This research study revealed that the response surface methodology central composite rotatable design can successfully be gotten the modelling of ansamycin polymeric nanoparticles.
引用
收藏
页码:279 / 291
页数:13
相关论文
共 25 条
  • [1] Optimization of microencapsulation of seed oil by response surface methodology
    Ahn, Jang-Hyuk
    Kim, Young-Pil
    Lee, Yu-Mi
    Seo, Eun-Mi
    Lee, Ki-Woong
    Kim, Hak-Sung
    [J]. FOOD CHEMISTRY, 2008, 107 (01) : 98 - 105
  • [2] [Anonymous], PHARM TECHNOLOGY
  • [3] Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol
    Budhian, A
    Siegel, SJ
    Winey, KI
    [J]. JOURNAL OF MICROENCAPSULATION, 2005, 22 (07) : 773 - 785
  • [4] Polymer nanocomposites: The "nano" effect on mechanical properties
    Crosby, Alfred J.
    Lee, Jong-Young
    [J]. POLYMER REVIEWS, 2007, 47 (02) : 217 - 229
  • [5] Trachea transplantation: from laboratory to patient
    Crowley, Claire
    Birchall, Martin
    Seifalian, Alexander M.
    [J]. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2015, 9 (04) : 357 - 367
  • [6] Carbon Nanotubes: Present and Future Commercial Applications
    De Volder, Michael F. L.
    Tawfick, Sameh H.
    Baughman, Ray H.
    Hart, A. John
    [J]. SCIENCE, 2013, 339 (6119) : 535 - 539
  • [7] A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases
    Ghose, AK
    Viswanadhan, VN
    Wendoloski, JJ
    [J]. JOURNAL OF COMBINATORIAL CHEMISTRY, 1999, 1 (01): : 55 - 68
  • [8] Lidocaine-loaded biodegradable nanospheres.: I.: Optimization of the drug incorporation into the polymer matrix
    Görner, T
    Gref, R
    Michenot, D
    Sommer, F
    Tran, MN
    Dellacherie, E
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 57 (03) : 259 - 268
  • [9] Core-Shell Structured High-k Polymer Nanocomposites for Energy Storage and Dielectric Applications
    Huang, Xingyi
    Jiang, Pingkai
    [J]. ADVANCED MATERIALS, 2015, 27 (03) : 546 - 554
  • [10] Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation
    Huang, YB
    Tsai, YH
    Yang, WC
    Chang, JS
    Wu, PC
    Takayama, K
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (03) : 607 - 614